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Abstract 
Background: We have previously shown that qualitative assessment of surface electrostatic 
potential of HLA class I molecules helps explain serological patterns of alloantibody binding. 
We have now used a novel computational approach to quantitate differences in surface 
electrostatic potential of HLA B-cell epitopes, and applied this to explain HLA Bw4 and Bw6 
antigenicity.  
Methods: Protein structure models of HLA class I alleles expressing either the Bw4 or Bw6 
epitope (defined by sequence motifs at positions 77-83) were generated using comparative 
structure prediction. The electrostatic potential in three-dimensional space encompassing the 
Bw4/Bw6 epitope was computed by solving the Poisson-Boltzmann equation and 
quantitatively compared in a pairwise, all-versus-all, fashion to produce distance matrices 
that cluster epitopes with similar electrostatics properties.  
Results: Quantitative comparison of surface electrostatic potential at the carboxyl terminal of 
the α1-helix of HLA class I alleles, corresponding to amino acid sequence motif 77-83, 
produced clustering of HLA molecules in three principal groups according to Bw4 or Bw6 
epitope expression. Remarkably, quantitative differences in electrostatic potential reflected 
known patterns of serological reactivity better than Bw4/Bw6 amino acid sequence motifs. 
Quantitative assessment of epitope electrostatic potential allowed the impact of known amino 
acid substitutions (HLA-B*07:02 R79G, R82L, G83R) that are critical for antibody binding 
to be predicted. 
Conclusion: We describe a novel approach for quantitating differences in HLA B-cell 
epitope electrostatic potential. Proof of principle is provided that this approach enables better 
assessment of HLA epitope antigenicity than amino acid sequence data alone and it may 
allow prediction of HLA immunogenicity. 
  
 
Introduction 
HLA mismatched allografts commonly provoke alloantibody responses directed against 
polymorphic amino acid motifs (B-cell epitopes) on the surface of donor HLA glycoproteins. 
Such B-cell responses are often refractory to conventional immunosuppressive agents and are 
a major cause of chronic graft rejection. The alloantibody response in recipients of grafts with 
multiple HLA mismatches is usually directed against a small number (typically one or two) 
of immunodominant epitopes (1, 2). However, because polymorphic HLA molecules have 
evolved from common ancestral HLA types many epitopes are shared by different HLA 
specificities resulting in a high degree of serological cross-reactivity. For a potential 
transplant recipient with a given HLA type, the ability to predict the relative immunogenicity 
to different HLA alloantigens would enable a more rational approach to donor selection, 
thereby avoiding HLA mismatches most likely to evoke a strong alloantibody response.  
 
The immunogenicity of HLA class I and class II mismatches can be predicted by interlocus 
subtraction of amino acid sequence motifs (triplets and eplets) that define immunogenic 
epitopes associated with alloantibody production and renal transplant outcome (3-5). 
However, defining epitopes based on amino acid sequence comparison alone provides an 
incomplete description of the immunogenicity of an epitope. The specificity and affinity of 
antibody-antigen interactions are largely governed by electrostatic forces dictated by the 
number and distribution of charged atoms on the surface of the HLA molecule (6-8). 
Moreover, amino acid polymorphisms outwith an epitope may alter its tertiary structure and 
electrostatic pattern (9). Consequently epitopes with an identical amino acid sequence 
expressed on different HLA molecules may present widely differing electrostatic patterns 
because of topographical alterations imposed by distant amino acid polymorphisms (9). 
Conversely, common structural electrostatic motifs may be conserved between HLA 
molecules despite variation in the amino acid sequence motif because of conservative amino 
acid substitutions with side chains that have similar physiochemical properties.  
 
We have previously used atomic resolution structural modelling to define the surface 
electrostatic potential of HLA class I molecules in order to understand better the molecular 
basis for alloantibody binding epitopes and to predict their relative ability to evoke a humoral 
response (9). This approach provided novel qualitative insights into the heterogeneity of 
HLA-specific antibody binding that could not be explained by amino acid sequence 
comparisons alone. We have now applied methods to quantitatively assess differences in the 
surface electrostatic patterns of HLA molecules and here we report our analysis of the two 
common HLA class I epitopes Bw4 and Bw6 that are serologically well-characterised with 
known amino acid sequence motifs. 
 
Materials and Methods 
 
Generation of structural and physiochemical models of HLA class I molecules. 
HLA class I structures, resolved using X-ray crystallography with a resolution of less than 1.5 
Å (PDB codes: 1K5N, 1X7Q, 1XH3, 2BVP, 3BWA, 3LN4, 3MRE, 3SPV), were used as 
templates to generate atomic resolution 3-D structural models of common HLA-A and –B 
alleles that express the Bw4 or Bw6 epitope, as previously described (9). HLA allele 
sequence data was retrieved from the IMGT/HLA database 
(ftp.ebi.ac.uk/pub/databases/ipd/imgt/hla). Mean sequence homology between templates and 
target sequences was 91.9% (range: 84.1%-100.0%). Because electrostatic forces are a 
critical determinant of antibody-antigen interaction, the electrostatic potential above the 
molecular surface of each HLA allele modelled was calculated (10). To standardise the 
peptide binding groove environment, all HLA class I structures were modelled with an 
alanine nonamer peptide. In brief, homology modelling was performed using the 
MODELLER computer algorithm (https://salilab.org/modeller/) (11) and the stereochemical 
quality of each model confirmed using Ramachandran plot (12), DOPE (13), Verify3D (14) 
and WHAT_CHECK (15) scores. Atom charges and radii were assigned and side-chains 
protonated for pH 7.4 using the PARSE force-field in PDB2PQR (16). The electrostatic 
potential in 3-D space of each HLA class I model was calculated by solving the linearised 
Poisson-Boltzmann equation in APBS (http://www.poissonboltzmann.org/) (10) for a cubic 
grid with sides of 353 points at a spacing of 0.33 Å (Figure 1). Other parameters were set as 
follows: ionic solution of 0.15 M of univalent positive and negative ions; protein dielectric of 
2; solvent dielectric of 78; temperature of 310 K; and a probe radius of 1.4 Å.  
 
Quantitative comparison of 3-D electrostatic potential of the Bw4 and Bw6 epitopes 
Electrostatic potential comparisons were performed based on the method described by Wade 
et al (http://pipsa.eml.org/pipsa/) (17, 18). In brief, this method considers the electrostatic 
potential in a ‘skin’ above the molecular surface of a protein and quantitative comparison is 
performed for grid points within the intersection of the ‘skins’ of two superimposed proteins 
(18). For the purpose of this study, a ‘skin’ of 4 Å thickness and raised 3 Å above the 
molecular surface of HLA molecules was defined. To enable selective comparison of Bw4 
and Bw6 epitopes, a spherical region of interest was considered that encompasses the 
canonical Bw4/Bw6 sequence motif. The centre of the sphere was defined as the geometric 
average of the position of the side chain atoms of amino acids 77-83 and a radius of 10 Å was 
selected to encompass the Bw4/Bw6 residues of all superimposed HLA molecules. 
Electrostatic potential comparisons were made between grid points within the intersecting 
skins that were bounded by the sphere (Figure 1). This resulted in a median of 2640 grid 
point comparisons which were then used to calculate a similarity index (using the Hodgkin’s 
index (18, 19)) for the two epitopes being compared. The Hodgkin's index assigns values 
between 1 (electrostatic identity, both in magnitude and sign) and -1 (electrostatic 
anticorrelation of the sign of the potential but of the same magnitude), which were then 
convertedinto a distance (Electrostatic Similarity Distance [ESD] [(2-2SI)½]) to give values 
between 0 (electrostatic identity) and 2 (electrostatic anti-correlation) where 1 represents no 
apparent correlation. ESD was considered to 3 decimal places. For the purpose of this study, 
the electrostatic potential space overlaying the Bw4/Bw6 epitope was sampled using a sphere 
to identify relevant grid points; different approaches for sampling the electrostatic potential 
space (e.g. sphere radius of 8-12 Å, utilising a cone instead of a sphere and sampling from a 
skin of variable thickness and distance from the molecular surface) did not alter the results of 
the quantitative epitope comparisons (data not shown).  
 
Electrostatic potential comparisons were made for all possible combinations of common 
Bw4/Bw6 expressing HLA class I alleles studied (in a pairwise, all-versus-all, fashion). The 
ESDs generated by the epitope comparisons were compiled as a distance matrix that was then 
displayed as a symmetrical heatmap with re-ordering such that alleles with electrostatically 
similar epitopes cluster together. Symmetrical heatmaps and allele re-ordering were 
performed in R using complete-linkage hierarchical clustering as implemented in the hclust 
function (20). 
 
 
 
 
 
Results 
 
A novel approach for comparing electrostatic potential was employed to assess Bw4 and Bw6 
epitope antigenicity. Quantitative assessment of the surface electrostatic potential of Bw4 and 
Bw6 epitopes was undertaken by placing a sphere of 10 Å radius over the epitope to identify 
the relevant grid points. Paired comparisons of epitope surface electrostatic potential were 
made for all possible combinations of the 50 common Bw4/Bw6 expressing HLA class I 
alleles and the results, clustered according to ESD and depicted as a heatmap and 
dendrogram, are shown in Figure 2. When all alleles were compared there was substantial 
heterogeneity in ESD ranging from 0.000 to 1.918 (from a possible range of 0.000 to 2.000) 
with three principal clusters, two of which contained exclusively Bw6 expressing alleles 
(cluster A and B) and a third cluster (cluster C) of Bw4 expressing alleles. Within the three 
clusters there was further variation in ESD (cluster A 0.000 to 1.441; cluster B 0.063 to 
0.195; cluster C 0.000 to 0.989). Importantly, Bw4 expressing HLA-A alleles located 
appropriately within cluster C. The ability of ESD to segregate alleles expressing the 
serologically distinct Bw4 and Bw6 epitopes supports the concept that quantifying the 3-D 
surface electrostatic potential of an epitope accurately reflects well-characterised antibody 
binding patterns. The three Bw6 expressing alleles that comprise cluster B, (HLA-B*18:06, - 
B*46:01 and -B*73:01) are known not to bind Bw6 alloantibodies and it is notable that their 
epitope has distinct electrostatic properties to all the other Bw6 expressing alleles. We next 
extended the analysis to include HLA-B*07:02 alleles in which targeted point mutations have 
been introduced into the Bw6 epitope that have differing effects on Bw6- specific mAb 
binding (21) (Figure 3). The substitution of asparagine for threonine at position 80 (B*07:02 
N80T) does not affect Bw6 mAb binding (21). HLA-B*07:02 N80 and - B*07:02 T80 are 
both located in cluster A, indicating a limited effect of the mutation on Bw6 surface 
electrostatic potential. In contrast, substitution of arginine for glycine at position 79  
(HLA-B*07:02 R79G), arginine for leucine at position 82 (HLA-B*07:02 R82L) and glycine 
for arginine at position 83 (HLA-B*07:02 G83R) resulted in abrogation of Bw6 mAb binding 
(21). These mutated HLA-B*07:02 molecules were displaced from the native -B*07:02, 
present in cluster A, into cluster B reflecting marked alterations on epitope surface 
electrostatic potential. 
 
 
Discussion 
 
There is increasing awareness of the importance of epitope based HLA matching to offset the 
risk of humoral alloimmunity following renal transplantation. The major focus to date has 
been on amino acid sequence comparisons of donor and recipient HLA class I and II epitopes 
and this approach provides a better assessment of immunological compatibility than 
conventional HLA matching (3, 4, 22). We have shown previously that incorporating a 
physiochemical analysis of HLA alloantigens further improves predictions of 
immunogenicity (23-25) and that qualitative structural assessment of the electrostatic 
topography of HLA B-cell epitopes provides an explanation for serological patterns of HLA 
specific antibody binding (9). In the present study we have created atomic resolution 
molecular models of HLA class I and calculated the electrostatic potential on the 3-D surface 
of two common B-cell epitopes, Bw4 and Bw6, and applied these to understand better the 
molecular basis for alloantibody binding. Importantly, the novel quantitative approach 
described here can be used to compare 3-D surface electrostatic differences between HLA 
Bcell epitopes that may reflect their relative immunogenicity.  
 
We chose to focus our proof of principle analysis on Bw4 and Bw6 because they are widely 
expressed on different HLA class I molecules and are serologically well-characterised with 
known amino acid sequence motifs. When we compared the 3-D surface electrostatic 
potential of the carboxyl terminal of the α1 helix of HLA-A and -B alleles (corresponding to 
the position of Bw4 and Bw6), we observed that alleles segregated according to their 
expression of either Bw4 or Bw6 epitopes indicating that B-cell epitopes with common 
functional characteristics share similar 3-D surface electrostatic properties. In addition, 
analysis of HLA-B alleles in which targeted point mutations have been introduced into the 
Bw6 epitope showed that quantitative assessment of B-cell epitope electrostatic potential 
accurately reflects the functional impact of critical and non-critical amino acid substitutions 
on antibody binding. These observations validate the concept that quantitative assessment of 
electrostatic potential of a B-cell epitope has functional relevance and provides insight into 
alloantibody-HLA interactions that are not explicable in terms of amino acid sequence data 
alone.  
 
Our quantitative analysis revealed that three alleles expressing the Bw6 amino acid sequence 
motif had electrostatic properties distinct from those found on the majority of Bw6 
expressing alleles. These alleles are known not to bind Bw6 alloantibodies and it is 
interesting therefore that the epitope they express has distinct electrostatic characteristics. 
Moreover, within the two major Bw4 and Bw6 clusters there was further electrostatic 
heterogeneity. Electrostatic forces are key mediators of the affinity of antigen-antibody 
interactions (6, 8) and it is possible that such variation in electrostatic potential of the same 
B-cell epitope, when expressed on different HLA molecules, may be an important 
determinant for the functional outcome of antibody binding. This has obvious implications 
for understanding the clinical significance of HLA-specific antibodies in transplantation and 
it will be important to investigate this by subjecting computational predictions of specific 
HLA-alloantibody interactions to in vitro experimental validation.  
 
The interaction of antibody with antigen is a highly complex and dynamic process and it is 
important to emphasise that modelling this interaction was not the focus of the present study. 
Instead, our aim was to provide a computational method for comparing the physiochemical 
characteristics of an epitope as expressed by different HLA class I alleles to predict 
antigenicity and potentially immunogenicity. We focused our attention on the Bw4/Bw6 
epitope of HLA class I but acknowledge that the antibody binding "footprint" on the HLA 
molecule extends well beyond the "functional" epitope and that antibody/antigen interactions 
outwith an epitope may be important, particularly for stabilising the antibody/antigen 
interaction (3, 26, 27). It is also important to note that in this study, an alanine nonamer was 
modelled in the binding groove. Alanine was selected because it does not impose electrostatic 
or steric effects enabling, therefore, accurate prediction of HLA structure and epitope 
comparison between different HLA molecules. In contrast to the critical importance of 
peptide for recognition by alloreactive T cells, there is limited evidence for the role of peptide 
on HLA specific alloantibody binding (28). However, we acknowledge that certain peptides 
presented by the HLA class I molecule may have an effect on Bw4/Bw6 surface electrostatic 
potential, but this effect is likely to be limited; modelling this interaction would be complex 
and beyond the scope of this study. Finally, although protein electrostatic properties are the 
major determinant of antibody binding affinity, other physical properties of biomolecules, 
such as hydrophobicity, may also influence antibody binding and have only indirectly been 
taken into account in our analysis (29). 
 
In conclusion, the present study provides proof of concept that atomic resolution modelling 
and comparison of B-cell epitope 3-D surface electrostatic potential provides a 
physiochemical explanation for serological patterns of antibody binding. The quantitative 
comparison of epitope electrostatic potential between different HLA alleles may provide a 
novel tool for predicting HLA antigenicity and immunogenicity. 
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Figure 1. Schematic representation of the method used to quantitate the surface 
electrostatic potential of the Bw4 and Bw6 epitopes expressed on HLA class I molecules 
The HLA class I molecule is depicted in grey and the Bw4 or Bw6 epitope is highlighted in 
colour. (A) Atomic resolution 3-D structural models of common HLA-A and -B alleles that 
express the Bw4 or Bw6 epitope were created. (B) The electrostatic potential in the 3- 
dimensional space around each HLA class I model was calculated by solving the linearised 
Poisson-Boltzmann equation, as implemented in APBS, for a cubic grid with sides of 353 
points spaced 0.33 Å apart. (C and D) To enable selective electrostatic potential comparison 
of the Bw4 and Bw6 epitopes, a virtual sphere of interest (10 Å in radius) was created to 
encompass the canonical Bw4/Bw6 motif. Quantitative comparisons of the electrostatic 
potential of the Bw4/Bw6 epitope were made for each HLA allele by comparing electrostatic 
potential at analogous grid points within the sphere of interest. 
 
 
 
 
  
 
 
Figure 2. 
  
 
 
 
 
 
Figure 2. Heatmap and dendrogram of Bw4/Bw6 epitope electrostatic potential 
similarity between HLA class I alleles 
Epitope electrostatic potential comparisons were made for all possible combinations of 
common Bw4/Bw6 expressing HLA class I alleles (in a pairwise, all-versus-all, fashion). The 
Electrostatic Similarity Distances (ESD) generated by the epitope comparisons were 
compiled to form a distance matrix displayed as a symmetrical heatmap with re-ordering such 
that alleles with electrostatically similar epitopes are clustered together. There was substantial 
heterogeneity in ESD ranging from 0.000 to 1.918 resulting in three principal clusters, two of 
which contained exclusively Bw6 expressing alleles (cluster A and B) and a third cluster 
 (cluster C) of Bw4 expressing alleles. White squares represent electrostatic dissimilarity 
between two epitopes and darker shades of blue represent increasing similarity. The height of 
the dendrogram arms between a given allele pair is proportional to the electrostatic disparity 
of their epitopes. 
Figure 3. 
 
  
 
Figure 3. Heatmap and dendrogram of Bw4/Bw6 epitope electrostatic potential 
similarity between HLA class I alleles including mutant HLA-B*07:02 molecules 
Epitope electrostatic potential comparisons were performed for all possible combinations of 
Bw4/Bw6 expressing HLA class I alleles, including mutant HLA-B*07:02 molecules, in a 
pairwise, all-versus-all, fashion. The symmetrical heatmap and dendrogram were created as 
described in Methods and the Figure 2 legend. The amino acid substitution at position 80 
(B*07:02 N80T) did not affect Bw6 mAb binding and had a minimal effect on Bw6 epitope 
electrostatic potential. Amino acid substitutions leading to abrogation of Bw6 mAb binding 
(HLA-B*07:02 R79G, -B*07:02 R82L and -B*07:02 G83R), highlighted in grey, resulted in 
marked alterations of epitope surface electrostatic potential. 
 
 
